The growth of this market is mainly driven by increasing transplant procedures, technological advancements in transplant diagnostics, increasing public and private funding for targeted research activities, and increasing burden on infectious diseases driving the growth of the transplant diagnostics market.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=2531061
The transplant diagnostics market is expected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2019, at a CAGR of 7.2%.
Based on product, the reagents & consumables segment held the largest share of the market
On the basis of product, the transplant diagnostics market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of the global transplant diagnostics market
Based on technology, the molecular assays segment is expected to witness the highest growth during the forecast period.
On the basis of technology, the transplant diagnostics market is segmented into molecular assay and non-molecular assay technology. The molecular assay technology segment is expected to register the highest CAGR during the forecast period.
Based on the transplant type, the solid organ transplantation segment accounted for the largest share of this market.
On the basis of transplant type, the transplant diagnostics market is categorized into solid organ, stem cell, and soft tissue transplantation. Solid organ transplantation accounted for the largest share of the transplant diagnostics market
North America accounted for the largest share of the transplant diagnostics market
North America accounted for the largest share of the transplant diagnostics market in 2019, followed by Europe. This can primarily be attributed to the continuous commercialization of innovative transplant diagnostic products coupled with ongoing advancements in the field of genomics and proteomics, recent discovery genetic biomarkers & their clinical role in immunoassay testing, and the increasing prevalence of chronic and communicable diseases.
Some of the prominent players in the transplant diagnostics market are Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific Inc. (US), and bioMérieux S.A. (France). Others are Immucor, Inc. (US), Illumina, Inc. (US), Luminex Corporation (US), CareDx (US), Becton, Dickinson and Company (US), Hologic (US), and GenDx (Netherlands).
Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=2531061
Market Segmentation
This research report categorizes the transplant diagnostics market into the following segments and subsegments:
By Technology
- Molecular Assay Technologies
- PCR-Based Molecular Assays
- Real-time PCR
- Sequence-specific Primer-PCR
- Sequence-specific Oligonucleotide-PCR
- Other PCR-based Molecular Assays
- Sequencing-based Molecular Assays
- Sanger Sequencing
- Next-generation Sequencing
- Other Sequencing-based Molecular Assays
- PCR-Based Molecular Assays
- Non-molecular Assay Technologies
By Product & Service
- Reagents & Consumables
- Instruments
- Software & Services
By Transplant Type
- Solid Organ Transplantation
-
- Kidney Transplantation
- Liver Transplantation
- Heart Transplantation
- Lung Transplantation
- Pancreas Transplantation
- Other Organ Transplantations
-
- Stem Cell Transplantation
- Soft Tissue Transplantation
- Bone marrow Transplantation
By Application
- Diagnostic Applications
- Pre-transplantation Diagnostics
- Infectious Disease Testing
- Histocompatibility Testing
- Blood Profiling
- Post-transplantation Diagnostics
- Pre-transplantation Diagnostics
- Research Applications
By End User
- Independent Reference Laboratories
- Hospitals & Transplant Centers
- Research Laboratories & Academic Institutes
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
